Reducing Hereditary Cancer Act of 2025
Reducing Hereditary Cancer Act of 2025
Plain Language Summary
# Reducing Hereditary Cancer Act of 2025 - Summary **What the Bill Would Do:** This bill would expand Medicare coverage to pay for genetic testing that identifies hereditary cancer risk factors in patients who have a personal or family history of hereditary cancer. If passed, it would also cover risk-reducing surgeries and preventive screenings for Medicare beneficiaries found to carry these genetic mutations. Currently, Medicare coverage for such genetic testing and preventive procedures is limited, so this would broaden access to these services. **Who It Affects:** The bill primarily affects Medicare beneficiaries (generally people 65+) who have a family history of hereditary cancers or who have already been diagnosed with cancer potentially linked to genetic mutations. It could also indirectly benefit their family members by identifying hereditary cancer risks earlier.
Healthcare providers and the Medicare program itself would also be affected, as they would need to implement the new coverage policies. **Current Status:** As of now, the bill (S. 2760) is in committee and has not yet been voted on by the full Senate. Sponsored by Senator Lisa Murkowski (R-AK), it remains in the early stages of the legislative process.
CRS Official Summary
Reducing Hereditary Cancer Act of 2025This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Latest Action
Read twice and referred to the Committee on Finance.